Maternal and neonatal mortality · women with management of intra‐amniotic infection
1 finding from 1 review
All‐cause mortality WMD of · Adults (aged 40 or over) with COPD presenting with 1 or more exacerbations in the previous year. The 2 larger studies (Albert 2011; Sethi…
Antibiotics showed no clear difference in all‐cause mortality WMD of compared with placebo (moderate certainty).
1 finding from 1 review
Mortality before hospital discharge · symptomatic neonates born through meconium‐stained amniotic fluid
Antibiotics showed no clear difference in mortality (before discharge) compared with control (no antibiotics) (low certainty).
1 finding from 1 review
Mortality before hospital discharge · asymptomatic neonates born through meconium‐stained amniotic fluid
Antibiotics showed no clear difference in mortality (before discharge) compared with control (no antibiotics) (low certainty).
1 finding from 1 review
All‐cause mortality · adults with uncomplicated appendicitis
It is very uncertain whether antibiotics changes mortality compared with surgery (very low certainty).
1 finding from 1 review
Neonatal mortality · pregnant women with prelabour rupture of membranes at or near term
1 finding from 1 review
Perinatal mortality · pregnant women with prelabour rupture of membranes at or near term
Any antibiotic showed no clear difference in perinatal mortality compared with placebo or no antibiotic (low certainty).
1 finding from 1 review
All‐cause mortality · exacerbations of COPD
Antibiotics showed no clear difference in all‐cause mortality compared with placebo (low certainty).
1 finding from 1 review
All‐cause mortality · adult kidney transplant recipients
Antibiotics showed no clear difference in all‐cause mortality compared with no treatment (low certainty).
1 finding from 1 review
Mortality and morbidity prior to discharge (Neonatal intensive care admissions) · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
Antibiotic showed no clear difference in mortality and morbidity prior to discharge (Neonatal intensive care… compared with placebo (low certainty).
1 finding from 1 review
Mortality ‐ not reported · acute asthma exacerbation
The review found no eligible studies for this question.
1 finding from 1 review
All‐cause mortality maximum · patients with coronary heart disease
Antibiotics showed no clear difference in all‐cause mortality at maximum compared with placebo or no intervention (high certainty).
1 finding from 1 review
Maternal and neonatal mortality · women with management of intra‐amniotic infection
1 finding from 1 review
Inpatient mortality · exacerbations of COPD
Antibiotics showed no clear difference in all‐cause mortality ‐ inpatients compared with placebo (moderate certainty).
1 finding from 1 review
All‐cause mortality at 24±6 months · patients with coronary heart disease
Antibiotics leads to higher all‐cause mortality at 24±6 months compared with placebo or no intervention (high certainty).
1 finding from 1 review
ICU mortality · exacerbations of COPD
Antibiotics probably leads to lower all‐cause mortality ‐ ICU patients compared with placebo (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · patients with coronary heart disease
Antibiotics leads to higher cardiovascular mortality at 24±6 months compared with placebo or no intervention (high certainty).
2 findings from 1 review
All‐cause mortality · people undergoing laparotomy for penetrating abdominal trauma
1 finding from 1 review
Neonatal mortality ‐ oral antibiotic · neonates with sepsis
Comparison 1: route of antibiotic may leads to lower neonatal mortality ‐ oral antibiotic compared with standard care (low certainty).
1 finding from 1 review
All‐cause mortality · people undergoing laparotomy for penetrating abdominal trauma
It is very uncertain whether more than 24 hours of antibiotics changes mortality compared with 24 hours of antibiotics (very low certainty).
1 finding from 1 review